XORTX Therapeutics XRTX
NASDAQ XRTX
$0.98 -0.01 (-1.43%)
As of: Oct 21, 2026 · 1:50 PM EDT

XORTX Therapeutics (XRTX) Restructuring Costs (2021 - 2026)

Updated

XORTX Therapeutics (XRTX) recorded Restructuring Costs of $846.00 in the year ended Dec 31, 2020, up 101.4% from $420.00 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Restructuring Costs (2021 - 2026) Analysis & Trends

  • Per Business Quant data, XRTX's Restructuring Costs was $420.00 in the year ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 XORTX Therapeutics 924,958.32 -2.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33,155.00
Mar 31, 2026 47,474.00
Dec 31, 2025 31,645.00
Sep 30, 2025 22,592.00
Jun 30, 2025 43,734.00
Mar 31, 2025 22,364.00
Dec 31, 2024 24,845.00
Sep 30, 2024 30,823.00
Jun 30, 2024 56,053.00
Dec 31, 2023 21,764.29
Sep 30, 2023 34,180.03
Jun 30, 2023 35,265.46
Mar 31, 2023 35,032.76
Dec 31, 2022 23,044.07
Sep 30, 2022 19,249.16
Jun 30, 2022 29,728.86
Mar 31, 2022 20,940.84
Dec 31, 2021 93,485.93
Sep 30, 2021 23,239.65
API Access

XORTX Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=XRTX&period=max&api_key=YOUR_API_KEY